Shenzhen JYMed Technology Co.,Ltd is a high-tech enterprise engaged in research and develoment,manufaturing and commercialization of peptides based products including active pharmaceutical ingredient peptides,cosmetic peptides,and custom peptides as well as new peptide drug development. JYMed has two wholly-owned subsidiaries:Shenzhen JXBio Pharmaceutical Co.,Ltd and Hubei JX Pharmaceutical Co.,Ltd,which is under construction.

R&D center
JYMed’s R&D center, located in shenzhen, is set up for the research and development of new drug substances, peptide APIs and relevant products. The center is equipped with modern peptide synthesizer, large-capacity preparative purification system, and comprehensive analytical instruments including MS, HPLC, GC, UV, IC etc. The R&D center also provides technology support for both new drug discovery and manufacture process transferring.

Manufacturer Base
JYMed has peptide API Production lines in Nanjing in accordance with FDA cGMP compliance, and two finished dose production lines are in Shenzhen that can provide commercial batches of peptide dose including injectables, cartridge and freeze-dried powder etc. under cGMP guidelines. In addition, we are building up sixteen production lines for peptide API in Xianning, Hubei province, china, which will the one of the peptide API manufactuing bas